Do you qualify for a study at Glasgow Memory Clinic?
EU201 project – FUJIFILM Toyama
Alzheimer’s Disease (AD) is an increasingly common disease for which there is a need for treatments that address the underlying processes of the disease. In this study we are looking to address the increases in a protein called Tau, which is known to be present in patients with Alzheimer’s Disease.
We are looking to investigate a medication, which has demonstrated some ability to protect and preserve parts of the brain commonly affected by Alzheimer’s Disease. With this study, the researchers want to learn more about the safety and effectiveness of this new treatment.
Who can participate?
- You are between 50-80 years old
- You are diagnosed with mild cognitive impairment due to Alzheimer’s disease (MCI) or mild Alzheimer’s disease
- You have a close friend or relative who can accompany you to all the research center visits and, among other things, answer questions about your health and about your activities of daily living.
Please fill out our pre-screening survey below to check eligibility.